omarjavedbaqal Profile Banner
Omar Baqal, MD Profile
Omar Baqal, MD

@omarjavedbaqal

Followers
1K
Following
5K
Media
173
Statuses
1K

Cardiology fellow and Assistant Professor @mayoclinic @MayoAZCVFellows || #EPeeps⚡ #Afib enthusiast || Healthcare leadership and mentorship || Opinions = mine

Phoenix
Joined April 2016
Don't wanna be here? Send us removal request.
@Aravinth01
Aravinthan Vignarajah
3 days
Our latest article exploring the effect of GLP -1 RAs in VT now available @JACCJournals https://t.co/0IZrKsYPkU
1
3
8
@Sports_CardioNL
SportsCardiology
4 days
Abnormal electrocardiogram findings in athletes: A consensus statement of the European Association of Preventive Cardiology of the ESC https:/academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf646/8263812?login=true #ECG #SCD #SportsCardiology
1
24
57
@NEJM
NEJM
8 days
Presented at #AHA25: In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events. Full ADAPT
0
115
274
@drpablocorral
Pablo Corral MD
8 days
🚨 New breakthrough in prevention! 👉In the VESALIUS‑CV trial, Evolocumab added to high-intensity statin therapy reduced major adverse cardiovascular events (MACE) by 25% (HR 0.75; 95% CI 0.65-0.86) over ~4.6 years in patients who had no prior MI or stroke. 👉Absolute risk
19
75
216
@CircAHA
Circulation
8 days
#AHA25: VITAL-AF trial: Stressor-associated atrial fibrillation (AF) carries similar risks of stroke, bleeding, and death as primary AF ; yet patients are less likely to receive oral anticoa... https://t.co/KHusqqdQNr @JHaimovichMD @shaan_khurshid @MGHHeartHealth @MGBResearchNews
2
31
88
@JAMACardio
JAMA Cardiology
18 days
Among patients with #AtrialFibrillation, elevated BMI, and 1 or more additional cardiometabolic risk factors, aggressive risk factor management reduced arrhythmia recurrence over the 12-month period after catheter ablation. https://t.co/2SBgFqTLei
2
39
95
@peterkistler3
peterkistler MBBS PhD FHRS
28 days
What’s the obsession with PWI in AF ablation? It may appear “safe & easy” ⁦@drjohnm⁩ BUT no randomised evidence & there is downside #TWIC Oct 10
5
28
119
@narrowQRS
JMC
29 days
Quick patient lesson about types of ablation. Minor pros and cons. Part of upcoming "new and improved" patient education video about a.fib.
4
14
63
@drjohnm
John Mandrola, MD
1 month
20+ years ago, when momentum favored “more” ablation for pers AF, the Hamburg approach (Kuck) favored PVI alone first. STAR AF 2 proved them correct. Now this small study too. Less = more (at least w thermal ablation)
@hrs_journal
HeartRhythm
1 month
Pulmonary vein isolation and low-voltage area ablation in sinus rhythm for persistent atrial fibrillation: The SCAR-AF randomized trial https://t.co/0MLD3kSITJ
1
9
42
@hrs_journal
HeartRhythm
1 month
Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control https://t.co/lgvUuJyIb7
0
20
38
@UpBeatbyHRS
UpBeat by HRS
1 month
October is #SCAAwarenessMonth. Do you know the difference between a #heartattack and #suddencardiacarrest? 🫀 Heart attack = “plumbing problem” (blocked blood flow) ⚡ SCA = “electrical problem” (heart suddenly stops) SCA strikes without warning, and seconds matter. Recognizing
0
2
4
@omarjavedbaqal
Omar Baqal, MD
1 month
We highlight importance of careful analysis of inappropriate shocks in setting of multiple devices, considering device-device and drug-device interactions. Grateful to my mentors. @masry_hicham #Epeeps @MayoClinicCV @MayoAZCVFellows
@HRS_CaseReports
Heart Rhythm Case Reports
1 month
Inappropriate shocks from subcutaneous defibrillator (S-ICD) in the presence of a cardiac contractility modulation (CCM) device @omarjavedbaqal @MayoAZCVFellows @MayoClinicCV https://t.co/JfxOX8P5H7
1
1
8
@shaan_khurshid
Shaan Khurshid
2 months
Your patient develops #afib during acute illness or surgery. #afib goes away when stressor is gone. Will #afib come back? How to treat? Prevent? Answers and more in our new @JACCJournals state-of-the-art review on stressor-associated AF led by @JHaimovichMD & @ShinoKany ⬇️
4
76
230
@gautamsand
Sandeep Gautam
2 months
📢New in @hrs_journal *⃣ A rare Hypothesis-generating study on AF ablation in these days of almost mechanical #PFA 🌟Ectopy-triggering ganglionated plexus (ET-GP) ablation may be a solo strategy for persistent AF! ➡️ Study (n=49, Imperial College London): High-freq stimulation
1
12
31
@gautamsand
Sandeep Gautam
3 months
🧵: Establishing an AF Center of Excellence (CoE) *⃣AF is the most common sustained arrhythmia, driving morbidity, stroke, HF & costs worldwide. Care is fragmented & inconsistent. ➡️ The Heart Rhythm Society (HRS) has now published detailed criteria for AF Centers of Excellence
Tweet card summary image
heartrhythmjournal.com
Global population growth and a concomitant growth in the prevalence of cardiac disease have resulted in an atrial fibrillation (AF) epidemic with potentially serious untoward clinical outcomes...
2
3
12
@hrs_journal
HeartRhythm
3 months
Flecainide in Structural Heart Diseases: A Contemporary Reappraisal Beyond the CAST Trial https://t.co/4fLlVvdReg
1
42
99
@UpBeatbyHRS
UpBeat by HRS
3 months
⚡ What is #electrophysiology (EP)? Think of your heart as having its own electrical system, like wiring in a house. EP is the medical specialty dedicated to understanding these electrical signals. When something goes wrong with this "wiring," your heart might beat too fast,
0
2
5
@UpBeatbyHRS
UpBeat by HRS
3 months
Welcome to UpBeat ❤️ — your trusted source for expert-backed heart rhythm information, tools, and guidance, all powered by the Heart Rhythm Society! Whether you're navigating a new diagnosis, supporting a loved one, or simply staying informed about the latest in arrhythmia care,
0
3
8
@ASayedMD
Ahmed Sayed
4 months
Do heart transplant patients always need invasive angio to screen for graft vasculopathy❓ 📜 https://t.co/JVR5PRa1VN In this meta-analysis, CTA/PET had pretty respectable sensitivity/NPV for ruling out graft vasculopathy compared to a gold standard of invasive angiography.
3
11
34